In this episode of Category Leaders, Colin Brown and Martti Wallin explore the fascinating history of Roche, a Swiss pharmaceutical giant, from its origins in the 1890s to its evolution into a leader in biotech and diagnostics. Discover how strategic capital reallocation, innovation, and navigating geopolitical risks shaped its journey and contributed to modern medicine. This episode explores Roche's strategic evolution from a vitamins manufacturer to a biotech and precision medicine powerhouse. We analyse their innovative approach to diagnostics, biologics, and their system of scientific autonomy, governance, and process power that sustains their industry leadership.
